Studies: Celebrex doubles risk of serious heart problems

08/30/2006 | USA Today

Two studies suggest Celebrex, a pain reliever believed to help prevent colorectal polyps, poses such a danger to the heart that patients were warned not to take it to prevent colorectal disease. The Pfizer-made drug was shown to dramatically reduce the risk of recurrent polyps that can lead to cancer, but researchers found it doubled the risk of serious heart problems at the same time.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC